Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Alkermes, Inc.

Clinical trials sponsored by Alkermes, Inc., explained in plain language.

Alkermes, Inc. ALKS NASDAQ

A biopharmaceutical company developing treatments for central nervous system diseases.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 8 Not yet finished but already full! 1 Completed 2

New combo pill tested for long-term safety in teens with mental health conditions

Disease control ENROLLING_BY_INVITATION

This study is testing the long-term safety of a daily pill called OLZ/SAM (olanzapine plus samidorphan) in 236 teenagers with schizophrenia or bipolar I disorder. Participants have already completed a previous study with the same drug. The goal is to see if the drug is safe and t…

Phase: PHASE3 • Sponsor: Alkermes, Inc. • Aim: Disease control

Last updated Aug 16, 2026 00:00 UTC